- Home
- PRTA vs APPS Comparison
PRTA vs APPS Comparison
Compare PRTA & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | APPS |
|---|---|---|
| Founded | 2012 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.9M | 503.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRTA | APPS |
|---|---|---|
| Price | $9.27 | $5.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $18.86 | $6.25 |
| AVG Volume (30 Days) | 617.1K | ★ 2.3M |
| Earning Date | 11-06-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,786,000.00 | ★ $525,092,000.00 |
| Revenue This Year | N/A | $13.99 |
| Revenue Next Year | $819.08 | $11.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.82 |
| 52 Week Low | $4.32 | $1.41 |
| 52 Week High | $17.66 | $8.28 |
Technical Indicators
Market Signals| Indicator | PRTA | APPS |
|---|---|---|
| Relative Strength Index (RSI) | 36.68 | 51.79 |
| Support Level | $9.69 | $4.59 |
| Resistance Level | $10.50 | $5.70 |
| Average True Range (ATR) | 0.57 | 0.25 |
| MACD | -0.16 | 0.09 |
| Stochastic Oscillator | 6.50 | 56.11 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.